posted by Phill Allen
December, 06th, 2018
Novartis is to relocate its UK headquarters to White City Place Campus in London. The Swiss pharmaceutical giant whose national headquarters are currently based in Frimley Surrey, will move its 600 staff over to the capital, in a bid to join the city’s emerging life sciences cluster.
The drugs manufacturing giant will be joining a growing list of life science companies taking up residence in what has been dubbed the ‘golden triangle’ bioscience hub. Life sciences companies already on the site include T-cell therapy specialist Autolus and Synthace.
Haseeb Ahmad, Novartis UK country president told pharmatimes.com: “The nature of healthcare and medicine is changing and as we pivot towards becoming a focused medicines company we want to be closer to our customers and partners, and become better networked in the healthcare and life science ecosystem.” The area is also home to Imperial College London, which boasts biochemistry and medicine amongst its course offerings. It’s hoped the proximity between the two could lead to future partnerships in the future.
Professor David Gann, VP of Innovation at Imperial College London added: “Novartis is a natural fit for White City’s booming life sciences ecosystem, and we hope that this move will pave the way to new collaborations and partnerships to enhance our work in this area.”
News of the move comes as the company has undergone a restructuring process throughout its European operations, in a bid to save $1 billion from its annual costs.
Imperial College London, life science, London, Novartis, Pharmaceutical,
An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.